Intrexon takes a $60M flyer on a synthetic biology startup https://www.fiercebiotech.com/financials/intrexon-takes-a-60m-flyer-on-a-synthetic-biology-startup Billionaire R.J. Kirk's Intrexon ($XON) has signed a $60 million deal to acquire ActoGeniX, a Belgian biotech at work on oral drugs designed to generate therapeutic proteins and peptides from within the body. :}